Baudax Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, PA — Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that the Compensation Committee of Baudax Bio’s Board of Directors approved …
Read More